A Novel Cytidine Analog, RX-3117, Shows Potent Efficacy in Xenograft Models, even in Tumors that Are Resistant to Gemcitabine

M.Y. Yang, Y.B. Lee, C.H. Ahn, J. Kaye, T. Fine, R. Kashi, O. Ohne, K Smid, G.J. Peters, D.J. Kim

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)6951-6959
JournalAnticancer Research
Volume34
Issue number12
Publication statusPublished - 2014

Cite this

Yang, M. Y., Lee, Y. B., Ahn, C. H., Kaye, J., Fine, T., Kashi, R., ... Kim, D. J. (2014). A Novel Cytidine Analog, RX-3117, Shows Potent Efficacy in Xenograft Models, even in Tumors that Are Resistant to Gemcitabine. Anticancer Research, 34(12), 6951-6959.